Familial hypercholesterolaemia: open trials in Czechia

• NCT07058077

  A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

  Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC

  Fakultni nemocnice Brno, Brno · Fakultni Nemocnice Motol a Homolka, Prague · Vseobecna Fakultni Nemocnice V Praze, Prague 2

  Registry updated 2026-10-07

• NCT05682378

  Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Prague

  Registry updated 2026-09-18

• NCT06597019

  Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Prague

  Registry updated 2026-05-15

All Familial hypercholesterolaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error